Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ren-Lin Zheng

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|January 20, 2012
(2-Anilino-4-methyl-thia-zol-5-yl)(4-chloro-phen-yl)methanoneJing-Jing Liu, Ren-Lin Zheng, Sheng-Yong Yang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Ethyl 3-(4-methyl-benzene-sulfonamido)thieno[2,3-b]pyridine-2-carboxyl-ateWen-Qin Zhang, Ren-Lin Zheng, Hang Song, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Ethyl 3-amino-4H-thieno[2,3-b]pyridine-2-carboxyl-ateRen-Lin Zheng, Wen-Qin Zhang, Luo-Ting Yu, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
4-(4-Nitro-benz-yl)morpholineLing-Ling Yang, Ren-Lin Zheng, Guo-Bo Li, et al.
Journal of Biomolecular Structure & Dynamics|June 24, 2011
Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitorsHuan-Zhang Xie, Ling-Yun Liu, Ji-Xia Ren, et al.
Molecular Diversity|February 12, 2014
Structural modification of an EGFR inhibitor that showed weak off-target activity against RET leading to the discovery of a potent RET inhibitorQi-Zheng Sun, Yong Xu, Jing-Jing Liu, et al.
Journal of Chemical Information and Modeling|May 31, 2011
Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular dockingJi-Xia Ren, Lin-Li Li, Ren-Lin Zheng, et al.
Cancer Letters|September 28, 2011
Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivoYou-Zhi Xu, Ren-Lin Zheng, Yan Zhou, et al.
Journal of Medicinal Chemistry|November 3, 2012
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutationsJiao Yang, Li-Jiao Wang, Jing-Jing Liu, et al.
Chemmedchem|February 9, 2010
Taking quinazoline as a general support-Nog to design potent and selective kinase inhibitors: application to FMS-like tyrosine kinase 3Wei-Wei Li, Jin-Juan Chen, Ren-Lin Zheng, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Acta Crystallographica. Section E, Structure Reports Online|January 20, 2012
(2-Anilino-4-methyl-thia-zol-5-yl)(4-chloro-phen-yl)methanoneJing-Jing Liu, Ren-Lin Zheng, Sheng-Yong Yang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Ethyl 3-(4-methyl-benzene-sulfonamido)thieno[2,3-b]pyridine-2-carboxyl-ateWen-Qin Zhang, Ren-Lin Zheng, Hang Song, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Ethyl 3-amino-4H-thieno[2,3-b]pyridine-2-carboxyl-ateRen-Lin Zheng, Wen-Qin Zhang, Luo-Ting Yu, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
4-(4-Nitro-benz-yl)morpholineLing-Ling Yang, Ren-Lin Zheng, Guo-Bo Li, et al.
Journal of Biomolecular Structure & Dynamics|June 24, 2011
Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitorsHuan-Zhang Xie, Ling-Yun Liu, Ji-Xia Ren, et al.
Molecular Diversity|February 12, 2014
Structural modification of an EGFR inhibitor that showed weak off-target activity against RET leading to the discovery of a potent RET inhibitorQi-Zheng Sun, Yong Xu, Jing-Jing Liu, et al.
Journal of Chemical Information and Modeling|May 31, 2011
Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular dockingJi-Xia Ren, Lin-Li Li, Ren-Lin Zheng, et al.
Cancer Letters|September 28, 2011
Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivoYou-Zhi Xu, Ren-Lin Zheng, Yan Zhou, et al.
Journal of Medicinal Chemistry|November 3, 2012
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutationsJiao Yang, Li-Jiao Wang, Jing-Jing Liu, et al.
Chemmedchem|February 9, 2010
Taking quinazoline as a general support-Nog to design potent and selective kinase inhibitors: application to FMS-like tyrosine kinase 3Wei-Wei Li, Jin-Juan Chen, Ren-Lin Zheng, et al.
Pageof 2